NewsBenzingaBarclays Maintains Overweight on Coupang, Raises Price Target to $32 Barclays Maintains Overweight on Coupang, Raises Price Target to $32 Benzinga 2026.11.05 18:21 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Redwire, Lowers Price Target to $13 RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $18 Canaccord Genuity Maintains Buy on NuScale Power, Lowers Price Target to $11 RBC Capital Maintains Outperform on Veeva Systems, Raises Price Target to $365 Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $120 RBC Capital Maintains Outperform on VSE, Raises Price Target to $225
